The Food and Drug Administration (FDA)’s website, Current and Resolved Drug Shortages and Discontinuations Reported to FDA, designates Semaglutide (Ozempic) as “Currently in Shortage.”
The CDC is asking all healthcare professionals in the United States to be on alert for patients who have key characteristics for identifying monkeypox.
